Twist Bioscience Corporat... (TWST)
NASDAQ: TWST
· Real-Time Price · USD
32.63
-0.16 (-0.49%)
At close: Oct 09, 2025, 10:40 AM
-0.49% (1D)
| Bid | 23.65 |
| Market Cap | 1.97B |
| Revenue (ttm) | 362.27M |
| Net Income (ttm) | -85.19M |
| EPS (ttm) | -1.44 |
| PE Ratio (ttm) | -22.66 |
| Forward PE | -23.4 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 42.03 |
| Volume | 219,216 |
| Avg. Volume (20D) | 1,918,483.4 |
| Open | 32.75 |
| Previous Close | 32.79 |
| Day's Range | 32.46 - 33.52 |
| 52-Week Range | 24.07 - 55.33 |
| Beta | 2.39 |
| Ex-Dividend Date | n/a |
About TWST
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TWST
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TWST stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsTwist Bioscience Corporation is scheduled to release its earnings on
Nov 17, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-10.3%
Twist Bioscience shares are trading lower after th...
Unlock content with
Pro Subscription
5 months ago
-8.44%
Twist Bioscience shares are trading lower after the company reported a Q2 EPS miss.
2 months ago · businesswire.com
Twist Bioscience Appoints Trynka Shineman Blake to Board of DirectorsSOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth equity, today announced the appointment of Trynka Shineman Blake to its board of direct...
